As of 12:44pm ET
| +0.0009 / +0.26%|
The 1 analysts offering 12-month price forecasts for Tenax Therapeutics Inc have a median target of 1.50, with a high estimate of 1.50 and a low estimate of 1.50. The median estimate represents a +334.78% increase from the last price of 0.35.
The current consensus among 1 polled investment analysts is to Buy stock in Tenax Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.